Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited has announced the issuance of 1,743,019 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) as of September 24, 2025. This move is part of a dividend or distribution plan, potentially enhancing the company’s capital base and market presence, thereby impacting its stakeholders positively by increasing liquidity and shareholder value.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a wide range of products and services including medical supplies, pharmaceuticals, and animal care products. The company focuses on serving both the human and animal healthcare markets across Australia and New Zealand.
Average Trading Volume: 135,982
Technical Sentiment Signal: Sell
Current Market Cap: A$5.19B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.